Topics and Expertise: Food and Drug Administration (FDA)

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

The patient perspective on prosthetic limbs currently doesn’t factor into the FDA approval process. Leslie Wilson and Matthew Garibaldi are surveying patient preferences to speed access to the next generation of prosthetics.

Reprinted courtesy of UCSF Magazine.

In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.

She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their...

If you are a pharmaceutical company seeking to switch your prescription medication to one sold directly to consumers—as an over-the-counter or OTC drug—William Soller, PhD, has your road map.

The 2005 potential avian flu pandemic caused a shortage of antiviral drugs, leading to concerns about access, efficacy, and distribution.

The same level of legal scrutiny that applies to research funded by the US government should apply to research funded by industry, according to UCSF School of Pharmacy faculty member Lisa Bero, PhD, and co-authors of a study that appeared July 20, 2005 in the online issue of American Journal of...